Short-form video has taken over social media and attracted attention from advertisers. As brands shift their advertising spending to short-form video social platforms, doubts remain about the advertising efficacy on these platforms, especially given the skyrocketing advertising costs in recent years. In a large-scale randomized experiment on ByteDance in collaboration with an automobile brand, we show a significant effect of the advertising campaign on ByteDance, compared with effects reported in other studies. Exposed users are eight times more likely to convert from outside than from within ByteDance, which raises the importance of information sharing between the platform and brands. When considering conversions outside ByteDance, the average cost per conversion, which brands commonly use to evaluate the cost of campaigns, shrinks by 5 or 25 times, depending on the methods used to calculate it. Information sharing can also affect a brand’s targeting strategy. While commonly used demographic variables by the automobile brand are effective for target marketing with only platform data, they are not when considering conversions outside ByteDance. Instead, a behavioral variable proposed herein (prior brand home page visits) effectively moderates the advertising effect but has no effect when including only platform data in the analysis.

Alzheimer's disease (AD) is a progressive and evolving neurodegenerative disease with an insidious onset that can lead to memory loss and cognitive impairment. There is no effective treatment for this disease. However, early diagnosis plays an important role in treatment planning to slow down its progression, as treatment has the greatest impact in the early stages of the disease. Neurological images obtained through different imaging techniques provide powerful information and help diagnose the disease. With the wide application of deep learning techniques in disease diagnosis, especially the prominence of Convolutional Neural Networks (CNNs) in computer vision and image processing, more and more studies are proposing the use of this algorithm for the diagnosis of AD. In this paper, we first systematically introduce the impact of AD on people, detailing the biomarkers, early clinical symptoms, and risk factors of this disease. Secondly, it goes on to detail the development of CNNs, their form, and methods to help diagnose AD. It is proposed that CNNs can help diagnose AD by analyzing medical imaging data, particularly structural brain scans such as magnetic resonance imaging (MRI) and functional scans such as positron emission tomography (PET). Finally, it is concluded that CNNs are of great importance for the diagnosis of AD and that they are likely to play an increasingly important role in the early detection of the disease, the understanding of disease mechanisms, and ultimately, in the development of effective AD therapies and interventions. CNNs are playing an increasingly important role in the Their potential impact on healthcare emphasizes the importance of continued research and innovation in neural networks and medical imaging.

The present article analyzes the results of recent clinical trials of beta secretase inhibition in sporadic Alzheimer’ disease (SAD), considers the striking dichotomy between successes in tests of BACE1 inhibitors in healthy subjects and familial AD (FAD) models versus persistent failures of clinical trials and interprets it as a confirmation of key predictions for a mechanism of APP-independent, beta secretase inhibition-resistant production of beta amyloid in SAD, previously proposed by us. In the light of this concept, FAD and SAD should be regarded as distinctly different diseases as far as beta-amyloid generation mechanisms are concerned, and whereas beta secretase inhibition would be neither applicable nor effective in treatment of SAD, the BACE1 inhibitor(s) deemed failed in SAD trials could be perfectly suitable for treatment of FAD. Moreover, targeting the aspects of AD other than cleavages of the APP by beta and alpha secretases should have analogous impacts in both FAD and SAD.

Alzheimer’s Disease (AD), a progressive and debilitating condition, is reported to be the most common type of dementia, with at least 55 million people believed to be currently affected. Many causation hypotheses of AD exist, yet the intriguing link between viral infection and its possible contribution to the known etiology of AD has become an attractive focal point of research for the field and a challenging study task. In this review, we will explore the historical perspective and milestones that led the field to investigate the viral connection to AD. Specifically, several viruses such as Herpes Simplex Virus 1 (HSV-1), Zika virus (ZIKV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), along with several others mentioned, include the various viruses presently considered within the field. We delve into the strong evidence implicating these viruses in the development of AD. We will also extend beyond these mere associations by carefully analyzing the potential mechanisms by which viruses may contribute to AD pathology. This includes but is not limited to direct neuronal infections, dysregulation of immune responses, and the impact on protein processing. Controversies and challenges of the viral-AD relationship emerge as we tease out these potential mechanisms considered. Looking forward, we emphasize the future directions the field should take to tackle the remaining unanswered questions and the glaring research gaps that persist. Overall, this review aims to provide a comprehensive survey of the past, present, and future of the potential link between viral infections and their association with AD development.

Type 2 Diabetes Mellitus and Alzheimer's disease are two diseases with a high incidence today that share similar pathophysiological mechanisms suggesting a potential causal relationship between them. In fact, Alzheimer-associated Mellitus Diabetes is also known as Type 3 Diabetes Mellitus and constitutes a diabetes intricately linked to Alzheimer's disease. Central to this association is insulin resistance, a key factor leading to decreased insulin sensitivity, hyperglycemia, and impaired glucose uptake. Because of this, the brain is altered resulting in energy deficits and neuronal damage associated with neurodegenerative disorder characteristic of Alzheimer's disease. Both diseases exhibit common biochemical and physiological characteristics such as inflammation, mitochondrial dysfunction, oxidative stress, and the formation of advanced glycation end products. Understanding the complex pathophysiology of Type 3 Mellitus Diabetes and identifying common features shared with Diabetes and Alzheimer's disease are essential steps towards potential therapeutic interventions targeting the insulin resistance pathway. The authors of this review on the relationships between type 2 diabetes and Alzheimer's disease have developed two works. In the first (Relationships between Type 2 Diabetes Mellitus and Alzheimer's Disease. I. Common pathogenic mechanisms), authors explore the shared (physiological, genetics and molecular) pathological changes occurring in Type 2 Mellitus Diabetes and Alzheimer's disease as well as pathways such as AMPK, PPARγ, cAMP, and PI3K/Akt as potential targets for managing Type 3 Diabetes Mellitus. By exploring these intricate mechanisms, the goal is to uncover their interdependencies and facilitate the discovery of innovative pharmacological and nutritional (epigenetics) strategies. In the second paper (Relationships between Type 2 Diabetes Mellitus and Alzheimer's Disease. II Potential therapies) we describe possible nutritional intervention, particularly dietary patterns and phytochemicals that can enhance the effects of pharmaceutical drugs designed against pathological mechanisms involved in the complex dual disease Type 2 Diabetes Mellitus and Alzheimer's disease (or in Type 3 Diabetes Mellitus as other authors consider).

The historical residential area of Kōm ad–Dikka in Alexandria has experienced subsequent morphological transformation since the ancient era until present. Each historical period had a physical impact on the city’s urban structure that in turn struggled to survive its successive one with its different urban conception. However, the sinuous streets of this area, which probably date back to the late Egyptian Medieval period, are characterized as the only surviving organic fabric intra–muros that was not altered during the Egyptian Modern period. This paper elaborately investigated the chronological history of the historical residential area since the ancient era until the mid—twentieth century. Based on in–depth investigation of historical maps and memoirs, it revealed the possible reasons behind its extant sinuous urban form and postulated reconstructions of its urban morphology through sequential phases.

It is a challenging issue to provide a secure and conditional anonymous authentication scheme in vehicle ad hoc networks(VANETs) with low storage space and computational cost. In 2008, Lu et al. [8] proposed an conditional privacy preservation scheme called ECPP protocol. The ECPP protocol provides conditional privacy preservation to vehicles in VANETs, that is, on one hand vehicles can achieve anonymous authentication in the network, on the other hand allow to be traced and revoked if necessary. However, ECPP scheme suffers from large storage and high computational cost. In our scheme, an improved protocol based on the concept of ECPP protocol has been proposed, which uses minimal interaction steps, little storage space and less computation overhead to achieve more efficiency conditional privacy preservation(MECPP) scheme in VANETs.

Forming a clustered network structure has been proposed as a solution to increase network performance, scalability, stability and manageability in an ad hoc network. A good clustering algorithm aims to select cluster heads among available nodes so that a number of specific constraints are satisfied; thus the cluster head selection problem is a multiobjective optimization problem. This paper proposes an algorithm on the basis of ant colony optimization (ACO) to be used to solve this problem. The proposed algorithm is a simple, one hop cluster formation algorithm, to form a clustered structure with the minimum number of clusters. The centralized ACO-based clustering algorithm is evaluated and compared with other clustering algorithms in ad hoc networks in terms of cluster density.

(1) Background: With the global population aging, the demand for effective rehabilitation products for the elderly is increasing. Traditional products often fail to meet the comprehensive needs of elderly users, who require solutions addressing physical, psychological, and social aspects; (2) Methods: Using the Analytic Hierarchy Process, Quality Function Deployment, Axiomatic Design, and the System Usability Scale to identify and prioritize user needs, market research and user interviews were conducted to understand the preferences of the elderly and obtain design specifications. The focus was on multimodal sensory feedback, which was validated through the study; (3) Results: Elderly users have a strong preference for rehabilitation products that are durable, easy to use and have comprehensive sensory feedback. Intelligent rehabilitation bed as the carrier, strengthened structure, high strength material, ergonomic adjustment, integrated health monitoring system. Using digital technology for real-time health monitoring and personalized feedback to provide a comprehensive recovery experience, high user satisfaction was reported in the evaluation; (4) Conclusion: It is important to emphasize user-centered design and integrate multi-modal sensory feedback to meet the comprehensive rehabilitation needs of elderly users. Future studies should expand user samples and expert opinions to refine and validate the design and improve its effectiveness and usability.

Unmanned delivery technology using unmanned aerial vehicles (UAVs) has the potential to solve issues such as traffic congestion and labor shortages. We investigated a method to construct a route between the source and destination nodes in a wireless multi-hop network by installing a radio terminal in each house. If the relay functions of all nodes in the network are in operation, the number of control messages for route construction increases, and the message relay forwarding load of each node increases. Keeping all node pairs multi-hop connectivity, we establish a method to operate the relay function with as few nodes as possible. End nodes that have not activated the relay function connect to the relay node with the closest physical distance. In this paper, we propose methods for selecting nodes to operate the relay function. Specifically, one method is based on random selection, another method is based on the number of adjacent nodes, and a third method is based on the Multipoint Relay (MPR) of the Optimized Link State Routing Protocol (OLSR). For each method, we evaluate whether the route construction is available, the number of relay nodes, the total distance of constructed routes, and the distance in population-dense regions. We clarify the characteristics of each method, and the method based on MPR is the best for constructing a network suitable for UAV navigation routes. In addition, the smaller the number of relay nodes, the more unexpected collisions on the links due to route conflicts. We clarify the minimum node density required to apply the MPR method which reduces the number of relay nodes suppressing route conflicts.

This article explores the implementation of high accuracy GPS denied Ad-Hoc localization. There is little research on Ad-Hock UWB-enabled localization systems with mobile and stationary nodes. This work aims to demonstrate the localization of bicycle-modeled robots in a non-static environment through a mesh network of mobile, stationary robots and ultra-wideband sensors. The non-static environment adds a layer of complexity when actors can enter and exit the node’s field of view. The method starts with an initial localization step where each unmanned ground vehicle (UGV) uses the surrounding, available anchors to derive an initial local or, if possible, global position estimate. The initial localization uses a simplified implementation of the iterative multi-iteration Ad-Hoc Localization System (AHLos). This estimate was refined using an unscented Kalman filter (UKF) following a constant turn rate and velocity magnitude model (CTRV). The UKF fuses the robot’s odometry and the range measurements from the Decawave ultra-wideband receivers stationed on the network nodes. Through this position estimation stage, the robot broadcasts to its neighbors its estimated position to help the others further improve their localization estimates and localize themselves. This wave-like cycle of nodes helping to localize each other allows the network to act as a mobile Ad-Hoc localization network.

Alzheimer’s disease (AD) is one of the most prevailing neurodegenerative diseases in the world, which is characterized by memory dysfunction and the formation of tau and amyloid β (Aβ) aggregate in multiple brain regions, including the hippocampus and cortex. The formation of senile plaques involving tau hyperphosphorylation, fibrillar Aβ, and neurofibrillary tangles (NFTs) are used as pathological markers of AD, and eventually produces aggregation or misfolded protein. Importantly, it has been found that failure to degrade these aggregate-prone proteins leads to pathological consequences, such as synaptic impairment, cytotoxicity, neuronal atrophy, and memory deficits associated with AD. Recently, increasing evidences have been suggested that autophagy pathway plays a role as a central cellular protection system to prevent the toxicity induced by aggregate or misfolded proteins. Moreover, it has also been related that AD-related protein aggresomes could be selectively degraded by autophagosome and lysosomal fusion through autophagy pathway which is known as aggrephagy. Therefore, the regulation of autophagy might be served as a useful approach to modulate the formation of aggresome associated in AD. This review focuses on the recent improvements in the application of natural compounds and small molecules as a potential therapeutic approach for AD prevention and treatment via aggrephagy.

With the prevalence of smartphones, the scope of mobile applications has been significantly broadened in the past few years including almost every aspect of our daily life. Among the applications, message dissemination services play a significant role. Traditionally, users send messages to the servers, which forward them according to friend lists. This client-server architecture is efficient with the support of infrastructures, however, it restricts the application scope and may hinder the wide deployment of location-based mobile applications. This paper proposes a novel communication model called passive broadcast for local message dissemination. In this new model, each node does not maintain a connection state and data delivery is initialized by a receiver via a ’scan’ operation. The representative carriers of passive broadcast include Bluetooth and WiFi-Direct, both of which define a mandatory ‘peer discovery’ function. Passive broadcast features negligible cost for establishing and maintaining direct links and is extremely suitable for short message dissemination in proximity. Furthermore, we study the operation management in the proposed communication model with complete protocols and in-depth analysis for optimization. We prototyped our solution on commercial phones and evaluated it with extensive experiments and simulation.

Alzheimer's disease (AD) is a significant regular type of dementia that causes damage in brain cells. Early detection of AD acting as an essential role in global health care due to misdiagnosis and sharing many clinical sets with other types of dementia, and costly monitoring the progression of the disease over time by magnetic reasoning imaging (MRI) with consideration of human error in manual reading. Our proposed model, in the first stage, apply the medical dataset to a composite hybrid feature selection (CHFS) to extract new features for select the best features to improve the performance of the classification process due to eliminating obscures features. In the second stage, we applied a dataset to a stacked hybrid classification system to combine Jrip and random forest classifiers with six model evaluations as meta-classifier individually to improve the prediction of clinical diagnosis. All experiments conducted on a laptop with an Intel Core i7- 8750H CPU at 2.2 GHz and 16 G of ram running on windows 10 (64 bits). The dataset evaluated using an explorer set of weka data mining software for the analysis purpose. The experimental show that the proposed model of ‏(CHFS) feature extraction ‏performs better than principal component analysis (PCA), and lead to effectively reduced the false-negative rate with a relatively high overall accuracy with support vector machine (SVM) as meta-classifier of 96.50% compared to 68.83% which is considerably better than the previous state-of-the-art result. The receiver operating characteristic (ROC) curve was equal to 95.5%. Also, the experiment on MRI images Kaggle dataset of CNN classification process with 80.21% accuracy result. The results of the proposed model show an accurate classify Alzheimer's clinical samples against MRI neuroimaging for diagnoses AD at a low cost.

Vehicular ad hoc networks (VANET) are a subset of mobile ad hoc networks used to communicate between vehicles and infrastructure. During vehicular congestion communication, nodes compete to acquire channels, causing the channels to become congested. The congestion on the vehicle network results in increased delay and packet loss, resulting in reduced VANET performance. To address this problem, we developed a load-aware and priority adaptive traffic congestion control method in vehicular ad hoc networks (VANETs). The proposed scheme identifies less-congested road segments based on the network's load and reduces traffic congestion by suggesting other routes between nearby roadside units (RSUs). This research aims to improve the efficiency of the vehicular environment by utilizing the movement of vehicles with (RSUs) and sharing the traffic load between them. Simulation results demonstrate the effectiveness of the proposed protocol in reducing congestion and enhancing the overall performance of VANETs. To validate the proposed algorithm, we have implemented and tested the proposed algorithm using Network Simulator 3 (NS3) for Vehicle-to-Vehicle (V2V) and Vehicle-to-Infrastructure (V2I) communication scenarios and computed the performance of the algorithm on different parameters of the network. The simulation result of the proposed load aware and priority adaptive traffic congestion control method in VANET improved the packet delivery ratio, packet lost ratio, and end-to-end delay by 96%, 4.1%, and 1102 milliseconds, when compared to TDCCA value of 92%, 5.7%, and 1154 milliseconds, respectively

OSI model used to be common network model for years. In the case of ad hoc networks with dynamic topology and difficult radio communications conditions, gradual departure is happening from the classical kind of OSI network model with a clear delineation of layers (physical, channel, network, transport, application) to the cross-layer approach. The layers of the network model in ad hoc networks strongly influence each other. Thus, the cross-layer approach can improve the performance of an ad hoc network by jointly developing protocols using interaction and collaborative optimisation of multiple layers. The existing cross-layer methods classification is too complicated, because it’s based on the whole manifold of network model layers combinations, regardless their importance. In this work, we review ad hoc networks cross-layer methods, propose the new useful classification of cross-layer methods, and show future research directions in ad hoc networks cross-layer methods development. The proposed classification can help to simplify the goal-oriented cross-layer protocol development.

Abstract: This study presents a methodological framework for AD and MCI diagnosis using radiomic analysis of 18FDG-PET imaging and conducts non-invasive predictions and in-depth analysis of AD and MCI and the associated small number of regions and features. Our methodology follows a structured process commencing with data preprocessing and labeling, facilitating segmentation through FastSurfer, a tool that efficiently segments the brain into 95 ROIs using the DKT-atlas. Subsequently, Feature extraction was carried out using PyRadiomics, calculating 120 features for each of the 95 ROIs (11,400 per image). These extracted features form the foundation of our radiomics analysis, primarily for early diagnostic purposes. In the feature selection phase, we explored a set of eight commonly employed techniques, including ANOVA, PCA, and LASSO, originating from the four main categories, namely filtered, embedded, wrapper, and hybrid methods, to identify a pertinent subset of features. Our evaluation assessed the performance of nine classification methods, such as GradientBoosting, RandomForest, and GaussianNB, in conjunction with eight feature selection techniques. The choice of feature selection method and classifiers was predicated on their ability to achieve the best area under the ROC curve with independent data. For all three predictions AD vs. CN, AD vs. MCI, and CN vs. MCI the Random Forest (RF) classifier with LASSO feature selection demonstrated the highest accuracy with an AUC of 0.976 for AD vs CN, AUC=0.917 for AD vs MCI, and AUC=0.877 for MCI vs CN. In conclusion, our RAB-PET platform enables efficient AD and MCI diagnosis from FDG-PET images using a radiomics pipeline. It also offers a general hardware and software tool for the investigation of other brain disorders.

Telomeres are structures at the ends of eukaryotic chromosomes that help maintain genomic stability. During aging, telomere length gradually shortens, producing short telomeres, which are considered markers of premature cellular senescence. This is believed to contribute to age-related diseases, including Alzheimer's disease (AD) and based on this, several studies have hypothesized that telomere shortening may characterize AD. Current research, however, has been inconclusive regarding the direction of the association between leukocyte telomere length (LTL) and disease risk. We assessed the association between LTL and AD in a retrospective case-control study of a sample of 255 unrelated patients with late-onset AD (LOAD), including 120 sporadic cases and 135 with positive family history for LOAD, and a group of 279 cognitively healthy unrelated controls, which were all from Calabria, a region from south Italy. Following regression analysis, telomeres were found to be significantly shorter in LOAD cases than in controls (p<0.001 for both sporadic and familial cases). Interestingly, LTL were associated to disease risk independently of the presence of conventional risk factors (e.g., age, sex, MMSE scores, presence of the APOE-ε4 allele). Altogether, our findings lend support to the notion that LTL shortening may be an indicator of the patho-genesis of LOAD.

Atopic dermatitis (AD) is a chronic and allergic skin disease, however, there is no cure for the disease. Many studies have shown anti-AD potentials of red ginseng, while red ginseng marc (RGM) remained after the ginseng extraction is discarded as industrial waste. However, it is recently reported that RGM, particularly fermented RGM (fRGM), still contains the bioactive properties. Thus, anti-allergic effects of fRGM were examined in 2,4-dinitrochlorobenzene-induced AD-like mice model. The model was topically treated with distilled water (control), dexamethasone, or fRGM for six weeks. The treatments of fRGM alleviated the skin lesions and reduced serum IgE levels, compared with the control. The fRGM also reduced skin levels of lipid peroxidation and superoxide anion, however, increased glutathione contents, with down-regulated gene expressions for inflammatory mediators. The histopathological analyses demonstrated that fRGM suppressed the epidermal thickening, collagen deposition, and inflammatory cell and mast cell infiltration, which involved the anti-inflammatory, anti-oxidant, and anti-apoptotic effects. Further, fRGM suppressed hypertrophic changes and inflammatory responses in the spleen and lymph node. The beneficial effects were observed in the dexamethasone and fRGM groups, however, the antioxidant effects were evident only in the fRGM treatments. These provide useful information for developing fRGM as therapeutic sources for AD.

Opportunistic routing has emerged as one of the prominent solutions for efficient data delivery in ad hoc networks especially in highly dynamic scenarios. Opportunistic routing uses the broadcasting nature of the wireless medium to increase the number of potential forwarding nodes in the network, thereby improving the delivery rate. But most of the proposed opportunistic routing protocols suffer from increased duplicate data forwarding at the intermediate nodes in the network which leads to increase in traffic and reduced efficiency. We propose a novel method which uses acknowledgements for controlling the data forwarding by intermediate nodes and thereby eliminating most of the duplicate forwarding in the network. Simulation results show that our proposed method is much more efficient that all the major existing opportunistic protocols.

In urban Vehicular Ad Hoc Network (VANET) environments, buildings play a crucial role as they can act as obstacles that attenuate the transmission signal between vehicles. Quantifying the impact of buildings on the transmission quality is essential, especially in critical scenarios involving emergency vehicles, where reliable communication is of utmost importance. In this research, we propose a supervised learning approach based on artificial neural networks (ANNs) to develop a predictive model capable of estimating the level of signal degradation, represented by the bit error rate (BER), based on the obstacles perceived by moving emergency vehicles. By establishing a relationship between the level of signal degradation and the encountered obstacles, our proposed mechanism enables efficient routing decisions to be made prior to the transmission process. Consequently, data packets are routed through paths that exhibit the lowest BER. To gather the necessary training data, we employed SUMO and NS-3 simulations. The simulation results demonstrate that our developed model successfully learns and accurately estimates the BER for new data instances. Overall, our research contributes to enhancing the performance and reliability of communication in urban VANET environments, especially in critical scenarios involving emergency vehicles, by leveraging supervised learning and artificial neural networks to predict signal degradation levels and optimize routing decisions accordingly.

Molecular therapies exploiting mRNA vectors embody enormous potential, as evidenced by the utility of this technology for the context of the COVID-19 pandemic. None-the-less, broad implementation of these promising strategies has been restricted by the limited repertoires of delivery vehicles capable of mRNA transport. On this basis, we explored a strategy based on exploiting the well characterized entry biology of adenovirus. To this end, we studied an adenovirus-polylysine (AdpL) that embodied “piggyback” transport of the mRNA on the capsid exterior of adenovirus. We hypothesized that the efficient steps of Ad binding, receptor-mediated entry, and capsid-mediated endosome escape could provide an effective pathway for transport of mRNA to the cellular cytosol for transgene expression. Our studies confirmed that AdpL could mediate effective gene transfer of mRNA vectors in vitro and in vivo. Facets of this method may offer key utilities to feasibilize the promise of mRNA-based therapeutics.

Mobility models are used to evaluated the network protocols of the ad hoc network using the simulation. The random waypoint model is a model for mobility which is usually used for performance evaluation of ad-hoc mobile network. Mobile nodes have the dynamic mobility in the ad hoc network so the mobility model plays an important role to evaluate the protocol performance.In this article, we developed modify random waypoint mobility (MRWM) model based on random waypoint for the mobile ad hoc network. In this article, the comparative analysis of modifying random waypoint mobility and random waypoint model on the ad hoc On-Demand Distance Vector (AODV) routing protocol has been done for large wireless ad hoc network (100 nodes) with the random mobile environment for the 1800s simulation time. To enhance the confidence on the protocol widespread simulations were accomplished under heavy traffic (i.e. 80 nodes) condition. The proposed model protocol has been investigated with the performance metrics: throughput; packet delivery ratio; packet dropping ratio; the end to end delay and normalized routing overhead. The obtained results revealed that proposed modify random waypoint mobility model reduces the mobility as compared to the random waypoint mobility model and it is trace is more realist.

Background: Research continues to search for blood-based biomarkers sensitive to Alzheimer’s disease (AD) pathology during the initial stages when symptoms of cognitive decline are not yet apparent. A blood-based biomarker candidate is metalloprotein p53, the conformation of which was previously found to be altered in peripheral cells from individuals with mild cognitive impairment (MCI) and AD, presenting as an unfolded p53 (U-p53) conformational variant. Methods: Plasma samples from the well-characterized Australian Imaging, Biomarkers, and Lifestyle (AIBL) cohort were used to identify the clinically relevant AZ 284^® peptide, specifically present in samples from individuals with symptomatic AD. The AZ 284^® peptide, which is a marker of the U-p53 conformational variant (U-p53^AZ), was identified by immunoprecipitation (IP) with a novel U-p53 conformational variant-specific antibody followed by liquid chromatography (LC) tandem mass spectrometry (MS/MS) and protein sequencing. Using IP-LC surface-activated chemical ionization (SACI) MS/MS analysis, the prognostic and diagnostic performance of U-p53^AZ were examined in the longitudinal AIBL cohort, including 252 plasma samples derived from 214 elderly individuals. For the prognostic analyses, U-p53^AZ levels were assessed at 36, 72, and 90 months after baseline assessment. Results: The prognostic performance of U-p53^AZ to predict the progression to AD from preclinical or prodromal AD was high, with area under the receiver operating characteristic curve (AUC) values close to or above 0.90. Furthermore, U-p53^AZ predicted the progression to AD more than 6 years prior to symptom onset with positive and negative predictive values of about 90%. Additionally, the estimated prognostic performance of U-p53^AZ was superior to other main risk factors (i.e., age, sex, and either alone or in combination with amyloid status. Furthermore, U-p53^AZ had high diagnostic performance to differentiate cognitively normal individuals from those with AD (AUC values >0.88). Conclusion: These findings support the use of U-p53^AZ as a prognostic blood-based biomarker accurately predicting the progression to AD dementia during the preclinical and prodromal stages at least 6 years before receiving the clinical diagnosis of AD dementia.

Vehicular ad-hoc network (VANET) is a type of mobile network which is used for establishing connection between vehicles (M2M) and also between vehicles and nearby stationary equipment which are often road-side equipment. The main target of VANET is to provide security and convenience for the passengers. In order to achieve this goal, a special electronic device called OBU (On-Board Unit) is embedded in each vehicle which makes the connection between vehicles and between the vehicles and the road-side equipment possible. In this paper, the Location-Aware Clustering in Vehicular Ad-hoc Networks (LAC-VANET) is proposed. We try to achieve the main and major goal in VANET networks, i.e. fast propagation of security and urgent messages in ITS systems, using clustering and selecting the best cluster head based on Fuzzy logic such that the cluster head can transfer important information such as the obstacles and accidents detected on the road with a suitable speed and without creating a large traffic load in the vehicle network in order to notify other vehicles and prevent the danger and vehicle accidents. Moreover, LAC-VANET method is evaluated here via extensive simulations carried out in NS-2. The simulation results indicate that the VANET network performance metrics are improved in terms of average throughput, Packet Delivery Ratio (PDR), end to end delay, and packet loss rate.

5G Mobile Adhoc Networks (5G-MANETs) are a popular and agile solution for data transmission in local contexts, while maintaining communication with remote entities via 5G. These characteristics have established 5G-MANETs as versatile communication infrastructures for deploying contextual applications, leveraging physical proximity while exploiting the possibilities of the Internet. As a result, there is growing interest in exploring the potential of these networks and their performance in real-world scenarios. However, the management and monitoring of 5G-MANETs is challenging due to their inherent characteristics, such as highly variable topology, unstable connections, energy consumption of individual devices, message routing, and occasional inability to connect to 5G. Considering these challenges, the proposed work aims to address real-time monitoring of 5G-MANETs using a connection-aware Digital Twin (DT). The approach provides two main functions: offering a live virtual representation of the network, even in scenarios where multiple nodes lack 5G connectivity, and estimating the performance of the infrastructure, enabling the specification of customized conditions. To achieve this, a communication architecture is proposed, analyzing its components and defining the involved processes. The DT is implemented and evaluated in a laboratory setting, assessing its accuracy in representing the physical network under varying conditions of topology and Internet availability. The results show 100% accuracy for the DT in fully connected topologies, with ultra-low latency averaging under 80 ms, and suitable performance in partially connected contexts, with latency averages below 3000 ms.

Autophagy refers to the degradation of cytoplasmic constituents by a lysosomal-mediated pathway, which plays a critical role in maintaining cellular homeostasis. Importantly, dysregulation of autophagy has been implicated in multiple neurodegenerative disorders. Previous studies reported that autophagy affects the processing of amyloid precursor protein (APP), thus stimulating β‐amyloid (Aβ) production in Alzheimer’s disease (AD) eventually. Although the mechanism of autophagy modulation on APP processing and its pathogenesis has not yet been fully elucidated at the molecular level, but modulation of autophagy has received considerable attention as a promising approach for the treatment of AD. In the early stage of AD, Aβ may prompt autophagy to facilitate its removal via mTOR‐independent as well as-dependent pathways. However, a recent study proposed that autophagy processes are not properly regulated as AD continues to progress, and consequently, the production of Aβ tends to accumulate rapidly. Meanwhile, a number of autophagy-related genes (Atg) as well as APP genes are also thought to influence the development of AD, which may serve as a bi‐directional link to autophagy and AD pathology. In this review, we summarized current observations related to autophagy regulation and APP processing, focusing on their dynamic modifications associated with the progression of AD. Recent findings together highlight the essential role of autophagy in the removal and clearance of APP and Aβ deposition in the pathological condition of AD.

Opportunistic routing is the latest technique that uses the broadcasting nature of the wireless medium to increase the number of potential forwarding nodes in the network. This, in turn improves the delivery rate and reliability of data transmission in the network. Compared to all previous classes of routing protocols, opportunistic routing offers numerous advantages which is exploited by the latest applications for efficient communication and resource sharing in dynamic ad hoc networks. These applications provide dynamic communication in disaster recovery environments. The objective of this research work is to review and classify all the major opportunistic routing protocols proposed for dynamic ad hoc networks. Further the issues and challenges with each of these existing protocol is discussed and future research directions are put forward

The exploration and identification of targets and pathways for Atopic dermatitis (AD) treatment and diagnosis are critical for AD control. The conventional target exploration approach such as the literature review is not satisfying in terms of efficiency and accuracy. Recently, the bioinformatic approach is drawing attention for its unique advantage of high-volume data analysis for target and pathway exploration; Open Targets Platform is the targets source for this study to extract top 200 high-rank proteins from 3122 AD associated proteins. STRING, Cytoscape, CytoHubba, ClueGo, and CluePedia function had been applied for data analysis. The KEGG Mapper search & colour pathway was the pathway map resource for identified pathways; 23 key hub genes (VDR, KIT, BCL2L11, NFKBIA, KRAS, IL13, JAK2, STAT3, IL21, IL4R, REL, PDGFRB, FOXP3, RARA, RELB, EGFR, IL21R, MYC, CREBBP, NR3C1, IL2, JAK1, and KITLG). Additionally, 8 correlated pathways and the biological process had been identified; Through this study, a viable approach for target and pathway exploration had been presented. The identified AD targets and pathways will be tested for upcoming research for traditional Chinese medicinal herb interactions

Opportunistic routing uses the broadcasting nature of the wireless medium to increase the number of potential forwarding nodes in the network. This, in turn improves the delivery rate and reliability of data transmission in the network. Compared to all previous classes of protocols, opportunistic routing offers numerous advantages which is exploited by the latest applications for efficient communication and resource sharing in dynamic ad hoc networks. The objective of this research work is to review and classify all the major opportunistic routing protocols proposed for dynamic ad hoc networks. Further the issues and challenges with each of these existing protocol is discussed and future research directions are put forward.

Opportunistic Routing is a promising paradigm that has been proposed for efficient and reliable transfer of data packets in mobile ad hoc networks. This routing strategy takes advantage of the broadcasting nature of the wireless medium to increase the number of probable forwarding devices and improves the reliability of data transfer in the network. Opportunistic Routing utilizes the reception of the same broadcasted packet at multiple devices in the network and selects one best forwarder dynamically from the set of multiple receivers. A number of opportunistic routing protocols have been proposed over these years for effective data delivery in ad hoc networks. But as the speed and mobility of devices increases in the network, performances of the existing opportunistic routing protocols degrade considerably, leading to reduced Quality of Service and poor transmission efficiency. The exceptional potential of opportunistic routing is thus underutilized. In this research we introduce Optimized Opportunistic Routing (OOR) strategy that guarantee excellent Quality of Service and high transmission efficiency to the latest applications using opportunistic routing for communication in highly dynamic ad hoc networks. Simulation results show that our method achieve significant performance improvements compared to all other existing opportunistic routing protocols in highly dynamic mobile ad hoc networks.

This project designed a set of network security mechanisms for cloud applications in VANETs. At present, cloud computing is one of the government’s development priorities in the industry. We divide cloud into public, private, and hybrid clouds in this project. Vehicles or passengers can access road conditions or public transport information through the public cloud; public transportation can access current driving records and users can access relevant enterprise information on the private cloud and hybrid cloud is a combination of public and private clouds. Both cloud computing or VANETs require network and information security. At present, many researches on VANETs security only focus on message communication, and neglect information storage. Researches on cloud computing security only focus on information protection, and neglect user privacy and anonymity. This project designed a set of network and information security mechanisms in line with the requirements of Confidentiality, Authentication, Non-repudiation, Conditional Anonymity, and Conditional Untraceability. This project primarily needs to achieve the following: 1.an authentication mechanism to verify the identity of each other between the passenger and the vehicle and to verify the identity with Single Sign-On; 2. vehicle or user privacy and anonymity, which need to be able to replace the anonymous ID and related parameters for the vehicle or the user; 3. a private communication mechanism, which enables any vehicle or user to communicate privately; and 4. an information security encryption method, which can encrypt the information on a cloud server to avoid unauthorized access by internal personnel or hackers.

Objective: Fludeoxyglucose F18 positron emission tomography (FDG PET) can give early clues for diagnosing Alzheimer’s disease (AD). Our objective was to use the same scan to predict Apolipoprotein E4 (ApoE4), known to be a risk factor. A second objective was to determine the brain regions and imaging features associated with this gene allele that can potentially help elucidate the mechanisms of the disease and better comprehend the images. Method: We employed data from 112 participants from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). PET and structural MRI data were co-registered with ANTx, and the Freesurfer tool delineated 95 whole brain, 19 hippocampal, and 9 amygdala regions. Using PyRadiomics we extracted 120 radiomic features from these segments. We employed a hybrid feature selection strategy. The HistGradientBoosting (HGB) classifier was evaluated using stratified five-fold cross-validation. Results: The proposed radiomics model predicted the homozygous ApoE4 genotype, with an AUC of 0.945 an accuracy of 0.875, a sensitivity of 0.914, and a specificity of 0.838. Reducing the feature set to seven key features resulted in a slightly decreased performance (AUC: 0.889). The mean values of the features showed statistically significant (p<0.05) incremental deterioration between different groups of homozygous ApoE4 carriers. Conclusion: Our findings underscore the critical role of specific brain regions and associated features in differentiating ApoE4 carriers. The hippocampus, entorhinal cortex, amygdala, thalamus, and pars orbitalis exhibited significant associations with the ApoE4 genotype. By employing SHAP analysis, we identified key features driving model predictions, enhancing interpretability, and providing insights into the underlying pathophysiology.

A low-cost machine learning (ML) algorithm is proposed and discussed for spatial tracking of unknown, correlated signals in localized, ad-hoc wireless sensor networks. Each sensor is modeled as one neuron and a selected subset of these neurons are called to identify the spatial signal. The algorithm is implemented in two phases of spatial modeling and spatial tracking. The spatial signal is modeled using its M iso-contour lines at levels {ℓj}j=1M and those sensors that their sensor observations are in Δ margin of any of these levels report their sensor observations to the fusion center (FC) for spatial signal reconstruction. In spatial modeling phase, the number of these contour lines, their levels and a proper Δ are identified. In this phase, the algorithm may either use adaptive-weight stochastic gradient or scaled stochastic gradient method to select a proper Δ. Additive white Gaussian noise (AWGN) with zero mean is assumed along with the sensor observations. To reduce the observation noise’s effect, each sensor applies moving average filter on its observation to drastically reduce the effect of noise. The modeling performance, the cost and the convergence of the algorithm are discussed based on extensive computer simulations and reasoning. The algorithm is proposed for environmental monitoring. In this paper, the percentage of the communication attempts of wireless sensors is assumed as cost. Performance evaluation results show that the proposed spatial tracking approach is low cost and can model the spatial signal over time with the same performance as that of spatial modeling.

The proliferation of mobile and IoT devices, coupled with the advances in the wireless communication capabilities of these devices, have urged the need for novel communication paradigms for such heterogeneous hybrid networks. Researchers have proposed opportunistic routing as a means to leverage the potentials offered by such heterogeneous networks. While several proposals for multiple opportunistic routing protocols exist, only a few have explored fuzzy logic to evaluate wireless links status in the network to construct stable and faster paths towards the destinations. We propose FQ-AGO, a novel Fuzzy Logic Q-learning Based Asymmetric Link Aware and Geographic Opportunistic Routing scheme that leverages the presence of long-range transmission links to assign forwarding candidates towards a given destination. The proposed routing scheme utilizes fuzzy logic to evaluate whether a wireless link is useful or not by capturing multiple network metrics, the available bandwidth, link quality, node transmission power, and distance progress. Based on the fuzzy logic evaluation, the proposed routing scheme employs a Q-learning algorithm to select the best candidate set toward the destination. We implement FQ-AGO on the NS-3 simulator and compare the performance of the proposed routing scheme with three other relevant protocols: AODV, DSDV, and GOR. For precise analysis, we consider various network metrics to compare the performance of the routing protocols. Our simulation result validates our analysis and demonstrates remarkable performance improvements in terms of total network throughput, packet delivery ration, and end-to-end delay.

The object of this research is designing of new robot-to-robot communication system working in the middle of highway/roads to support mobile safety for approaching vehicles. The result of research project directs to a group of safety robot devices which induce a vehicle on a bypass route, as a vehicle guidance method using the same, and a vehicle safety guidance system. According to an embodiment of the present invention, a safety device includes a detector configured to detect a vehicle approaching the safety device, and an image projector configured to project an image onto a road surface approaching the vehicle when the detector recognizes an approach of the vehicle. It can include. According to the present invention, when it is necessary to guide the vehicle to the bypass route, the driver of the vehicle can grasp the detour route in time and move the vehicle to the next lane.

. The Tau protein is associated with microtubule function in the neuron and is crucial for normal axonal transport. In several different neurodegenerative disorders, Tau misfolding leads to hyper-phosphorylation (p-Tau) and intracellular p-Tau aggregates known as neurofibrillary tangles (NFTs). This is particularly evident in individuals with Down syndrome (DS), who develop Alzheimer’s disease-like (AD) neuropathology early in life with almost complete penetrance, associated with the development of dementia symptoms in their 40s or 50s. Our previous findings have shown that certain forms of p-Tau are present already in childhood in individuals with DS in neuron-derived exosomes, suggesting an early phosphorylation profile in this population that could influence the development of AD pathology. Misfolded p-Tau isoforms are known to be seeding competent and may be responsible for spreading AD pathology in different regions of the brain. This review is focused on the accumulation of p-Tau in the brain of individuals with DS and potential consequences for brain function.

This paper initiates the study of the mathematical aspects of the ad-hoc Lanzhou index. If G is a graph with the vertex set {x1,⋯,xn}, then the ad-hoc Lanzhou index of G is defined by Lz¯(G)=∑i=1ndi(n−1−di)2, where di represents the degree of the vertex xi. Several identities for the ad-hoc Lanzhou index, involving some existing topological indices are established. The problems of finding graphs with the extremum values of the ad-hoc Lanzhou index from the following sets of graphs are also attacked: (i) set of all connected ξ-cyclic graphs of a fixed order, (ii) set of all connected molecular ξ-cyclic graphs of a fixed order, (iii) set of all graphs of a fixed order, (iv) set of all connected molecular graphs of a fixed order.

Vehicle to vehicle (V2V) and Vehicle to infrastructure (V2I) or briefly V2X communications are the one of hot topics in automotive industry. Therefore, this situation is providing many advantages of connected vehicles and infrastructures which bring to human life. For instance, vehicles and road infrastructures which shares information with each other, provides a neat flow regulation, more ordered traffic flow and therefore jammed traffic dependent accident’s percentage will be decreased. On the other hand, security is the most important issue for these systems because the operation of V2X networks is completely dependent on uninterrupted and accurate information sharing. In the light of these information, in this paper we review security issues and current solution architectures. We also propose some open problems in this lively field.

Alzheimer’s disease (AD) is an age-related neurodegenerative disease and is clinically characterized by cognitive impairment, memory loss, and personality disorder. Oligomers of amyloid beta-peptides (Aβ) and enhanced oxidative stress in senile plaques are prevalent pathologic hallmarks of AD. In this study, we detected the behavioral performance of Lycium ruthenicum Murray anthocyanin (LRA) -treated rats using the Morris water maze test and then investigated the effect of LRA on oxidative damage, neuronal apoptosis, and inflammatory response induced by Aβ1–42. Our results showed that LRA treatment markedly ameliorated the behavioral performance of Aβ1–42-induced rats and reduced the level of malondialdehyde, formation of protein carbonyl, and 8-hydroxy-2’-deoxygua-nosine. Furthermore, LRA also inhibited activated astrocytes and neuroinflammation via suppression of glial fibrillary acidic protein and tumor necrosis factor-alpha in the hippocampus of Aβ1–42-treated rat brain. These data suggest that LRA could be a potential anti-oxidant and anti-neuroinflammatory agent for the treatment of AD.

Mitochondrial dysfunction plays a pivotal role in numerous complex diseases. Understanding the molecular mechanisms by which the “powerhouse of the cell” turns into the “factory of death” is an exciting yet challenging task that can unveil new therapeutic targets. The mitochondrial matrix protein CyPD is a peptidylprolyl cis-trans isomerase involved in the regulation of the permeability transition pore (mPTP). The mPTP is a multi-conductance channel in the inner mitochondrial membrane whose dysregulated opening can ultimately lead to cell death and whose involvement in pathology has been extensively documented over the past few decades. Moreover, several mPTP-independent CyPD interactions have been identified, indicating that CyPD could be involved in the fine regulation of several biochemical pathways. To further enrich the picture, CyPD undergoes several post-translational modifications that regulate both its activity and interaction to its clients. Here, we will dissect what is currently known about CyPD and critically review the most recent literature about its involvement in neurodegenerative disorders, focusing on Alzheimer’s Disease and Parkinson’s Disease, supporting the notion that CyPD could serve as a promising therapeutic target for the treatment of such conditions. Notably, significant efforts have been made to develop CyPD-specific inhibitors, which hold promise for the treatment of such complex disorders.

During the last years, epigenetic processes have emerged as important factors for many neurodegenerative diseases, such as Alzheimer’s diseases (AD). These complex diseases seem to have a heritable component; however, genome-wide association studies failed to identify the genetic loci involved in the eatiology. So, how can these changes be transmitted from one gen-eration to the next? Answering this question would allow us to understand how the environ-ment can affect human populations for multiple generations and explain the high prevalence of neurodegenerative diseases, such as AD. This review pays particular attention to the relationship among epigenetics, cognition, and neurodegeneration across generations, deepening the under-standing of the relevance of heritability in neurodegenerative diseases. In fact, we highlight some recent examples of EI induced by experiences, focusing on their contribution of processes in learning and memory, to point out new targets for therapeutic interventions. Here, we first describe the prominent role of epigenetic factors in memory processing. Then, we briefly discuss aspects of EI. And ends, we summarize evidence of how epigenetic marks inherited by experi-ence and/or environmental stimuli contribute to cognitive status offspring, since better knowledge of EI can provide clues in the appearance and development of age-related cognitive decline and AD.

The Internet of Things (IoT) is an emerging technology that aims to enable the interconnection of a large number of smart devices and heterogeneous networks. Ad hoc networks play an important role in the designing of IoT-enabled platforms due to their efficient, flexible, low-cost, and dynamic infrastructures. These networks utilize the available resources efficiently to maintain the Quality of Service (QoS) in a multi-hop communication. However, in a multi-hop communication, the relay nodes can be malicious, thus requiring a secured and reliable data transmission. In this paper, we propose a QoS-aware secured communication scheme for IoT-based networks (QoS-IoT). In QoS-IoT, a Sybil attack detection mechanism is used for the identification of Sybil nodes and their forged identities in multi-hop communication. %by high-power and mobile nodes. After Sybil nodes detection, an optimal contention window (CW) is selected for QoS provisioning, i.e., to achieve per-flow fairness and efficient utilization of the available bandwidth. In a multi-hop communication, the MAC layer protocols do not perform well in terms of fairness and throughput, especially when the nodes generate a large amount of data. It is because the MAC layer has no capability of providing QoS to prioritized or forwarding flows. We evaluate the performance of QoS-IoT in terms of Sybil attack detection, fairness, throughput, and buffer utilization. The simulation results show that the proposed scheme outperforms the existing schemes and significantly enhances the performance of the network with a large volume of data. Moreover, the proposed scheme is resilient against Sybil attack.

It is widely known that vitamin D receptors have been found in neurons and glial cells and their highest expression is in the hippocampus, hypothalamus, thalamus and subcortical grey nuclei, and substantia nigra. The vitamin D helps the regulation of neurotrophin, neural differentiation and maturation, through the control operation of growing factors synthesis (ie NGF and GDNF), the trafficking of the septo-hyppocampal pathway, and the control of the synthesis process of different neuromodulators (such as Ach, DA, and GABA). Based on these assumptions, we have written this review in order to summarize the potential role of vitamin D in neurological pathologies. The work could be titanic, and might result very fuzzy and even incoherent, if we would not have conjectured to taper our first intentions and devoted our interests towards three mainstreams: demyelinating pathologies, vascular syndromes and neurodegeneration. Due to the lack of effective therapeutic options, a part from the disease modifying strategies, the role of different risk factors should be investigated in neurology, as far as their correction may lead to the improvement of the cerebral conditions. We have explored the relationships between the gene-environmental influence and long term vitamin D deficiency, as a risk factor for the development of different types of neurological disorders, along with the role and the rationale of therapeutic trials with vitamin D implementation.

We propose a wave-like design on the surface of cathode channels (wave form cathode channels) to improve oxidant delivery to gas diffusion layers (GDLs) [1-2]. We performed experiments using PEMFCs combined with wave form surface design on cathodes. We varied the factors of the distance between wave-bumps (the Adhesive distance, AD), and the size of the wave-bumps (the Expansion ratio, ER). The ADs are 3, 4, and 5 times the size of the half-circle bump’s radius, and the ERs are 1/1.5, 1/2, and 1/3 times the channel’s height. We evaluated the performances of the fuel cells, and compared the current-voltage (I-V) relations. For comparison, we prepared PEMFCs with conventional flat-surfaced oxygen channels. Our aim in this work is to identify fuel cell operation by modifying the surface design of channels, and ultimately to find the optimal design of cathode channels that will maximize fuel cell performance.

INTRODUCTION: This study focusses on diagnosis of stages of AD (Alzheimer’s disease) including MCI (Mild Cognitive Impairment) from two data modalities - gene expression and clinical data of ADNI (Alzheimer’s Disease Neuroimaging Initiative ) participants using multiclassification. The gene expression dataset is highly imbalanced and of HDLSS (high-dimensional and low-sample-size) characteristics. This is the only study where multiclassification based AD stage diagnosis is done to identify multiple stages of Alzheimer. We are able to achieve the best multiclassification result in both the modalities and identify new genetic biomarkers. METHODS: Combination of XGBoost and SFBS (“Sequential Floating Backward Selection”) methods is used to select features. We are able to select the most effective 95 gene probsets out of 49,386. For clinical study data, 8 most effective biomarkers could be selected using SFBS. For both genomic and clinical data, DL (‘Deep Learning’) classifier is used to identify stages - CN (Cognitive Normal), MCI (Mild Cognitive Impairment), AD (Alzheimer’s Disease / Dementia). Because of high data imbalance in genomic data, border line oversampling is used for model training and original data for validation. RESULT & DISCUSSION: With clinical data, we achieved ‘ROC AUC’ scores 0.97, 0.95, 0.94 for CN, MCI, Dementia stage respectively . We achieve ‘ROC AUC’ scores 0.75, 0.74, 0.70 for CN, MCI, Dementia stage respectively and 0.67 for both micro average F1 scores and micro weighted F1 score. This is the best result so far for AD stage diagnosis from gene expression profile data through multiclassification with ADNI data. Results reflect that our multiclassification model can efficiently handle the imbalanced data of HDLSS nature to identify samples of minority class. MAPK14, ZNF835, MID1, HLA-DQA1, TEP1 are some of the new genes found to be associated with AD risk. DRAXIN, HSPA12B, USP47 etc. are found to be AD preventive or suppressor.

SIRT6 is a NAD+ dependent enzyme and stress response protein that has sparked the curiosity of a plethora of researchers in different branches of the biomedical sciences. A unique member of the known Sirtuin family, SIRT6 has several different functions in several different molecular pathways related to DNA repair, glycolysis, gluconeogenesis, tumorigenesis, neurodegeneration, cardiac hypertrophic responses and so on. Only in recent times however did the potential usefulness of SIRT6 come to light as we learned more about its biochemical activity, regulation, biological roles and structure [1]. Even until very recently, SIRT6 was known more for chromatin signaling but being a nascent topic of study, more information has been ascertained and its potential involvement in major human diseases namely, diabetes, cancer, neurodegenerative diseases and heart disease has been demonstrated. It is pivotal to explore the mechanistic workings of SIRT6 since future research may hold the key to engendering strategies, involving SIRT6, that may have significant implications for human health and expand upon possible treatment options. In this review, we are primarily concerned with exploring the latest understanding of SIRT6 and how it can alter the course of several life-threatening diseases that cripple today’s society such as processes related to aging, cancer, neurodegenerative diseases, heart disease and diabetes. In addition, SIRT6 has shown to be involved in liver disease, inflammation and bone related issues but more emphasis is given to the former. Lastly, any recent promising pharmacological investigations and study of potential therapeutic targets are also delineated in this review.

Alzheimer's Disease (AD) and Parkinson's Disease (PD) are two neurodegenerative diseases posing a significant disease burden due to their increasing prevalence and socio-economic cost. Traditional therapeutic approaches for these diseases exist but provide limited symptomatic relief without addressing the underlying pathologies. This review examines the potential of immunotherapy, specifically monoclonal antibodies (mAbs), as disease-modifying treatments for AD and PD. We analyze the pathological mechanisms of AD and PD, focusing on the roles of amyloid-beta (Aβ), tau (τ), and alpha-synuclein (α-syn) proteins. We discuss the latest advancements in mAbs therapies targeting these proteins, evaluating their efficacy in clinical trials and preclinical studies. We also explore the challenges faced in translating these therapies from bench to bedside, including issues related to safety, specificity, and clinical trial design. Additionally, we highlight future directions for research, emphasizing the need for combination therapies, improved biomarkers, and personalized treatment strategies. This review aims to provide insights into the current state and future potential of antibody-based immunotherapy in modifying the course of AD and PD, ultimately improving patient outcomes and quality of life.

Manufacturing environments, characterized by rapid, unpredictable changes, uncertainties, risks, and uncontrollable fluctuations, pose significant challenges to minimizing disruptions in processes. This study introduces an innovative approach that prioritizes curbing risk propagation among processes to enhance robustness. It emphasizes the integration of engineering management principles and modular design within manufacturing. Adopting a system engineering perspective, all manufacturing process activities are viewed as interrelated components within a unified system. By employing Axiomatic Design (AD) theory and the Design Structure Matrix (DSM) method, manufacturing process architecture is modularized, yielding heightened robustness. The proposed mathematical model equips engineering and manufacturing managers with a potent tool for designing robust processes while adeptly managing system complexity. The study's outcomes underscore a substantial enhancement in modularization, leading to elevated overall robustness in manufacturing processes. To validate the methodology, the architectural design of manufacturing processes is examined in a real-case scenario, specifically the Barez Industrial Group in Iran. This verification substantiates the 'manufacturing processes' of the case, presenting an optimally modularized architecture. The results affirm the proposed approach's efficacy, demonstrating improved modularization that contributes to bolstered robustness in manufacturing processes.

Chronic traumatic encephalopathy (CTE) is a unique neurodegenerative disease that is associated with repetitive head impacts (RHI) in both civilian and military settings. In 2014, the research criteria for the clinical manifestation of CTE, traumatic encephalopathy syndrome (TES) were proposed to improve the clinical identification and understanding of the complex neuropathological phenomena underlying CTE. This review provides a comprehensive overview of the current understanding of the neuropathological and clinical features of CTE, proposed biomarkers of traumatic brain injury (TBI) in both research and clinical settings, and a range of treatments based on previous preclinical and clinical research studies. Due to the heterogeneity of TBI, there is no universally agreed-upon serum, CSF, or neuroimaging marker for its diagnosis. However, as our understanding of this complex disease continues to evolve, it is likely that there will be more robust, early diagnostic methods and effective clinical treatments. This is especially important given the increasing evidence of a correlation between TBI and neurodegenerative conditions, such as Alzheimer's disease and CTE¹. As public awareness of these conditions grows, it is imperative to prioritize both basic and clinical research, as well as the implementation of necessary safe and preventative measures.

Patients with neurodegenerative diseases (NDDs) are rapidly increasing all over the world. Alzheimer’s disease (AD), Parkinson’s disease, Huntington’s disease (HD), frontotemporal lobar degeneration (FTLD) and many other diseases are classified as NDDs, however, no therapeutic drugs have been developed against NDDs yet. As common phenomenon, protein oligomers and aggregates (inclusion bodies) are formed in neurons, and they trigger neuronal cell death and/or axonal degeneration. We have investigated the mechanisms of NDDs, and discovered several chemicals and peptides have potential to cure NDDs. Here, we show phorbol 12-myristate 13-acetate (PMA) significantly inhibits aggregate formation and promotes neurite regeneration in human neuronal cell culture model of NDDs, FTLD and AD. We expressed R406W mutant tau protein found in FTLD patients in human neuroblastoma SH-SY5Y cells as FTLD cell culture model. These FTLD neuronal cells showed intracellular aggregate formation and impaired neurite growth. Addition of PMA to culture medium 60% suppressed aggregate formation. PMA also enhanced neurite growth to the normal level at nanomolar concentration. We cultured SH-SY5Y cells in the medium containing -amyloid (1-42) as AD cell culture model. In these cells, neurite growth was limited to less than 50% of controls by the treatment of -amyloid (1-42). Surprisingly, addition of PMA increased the number of cells with >10-fold neurite extension to seven times even in -amyloid (1-42) contained medium. Also, PMA increased the expression of several genes and proteins important for cell survival in both cell culture models. These results suggest PMA has unexpected potential for the drug development against NDDs.

Alzheimer's Disease (AD) represents the most frequent type of dementia in elderly people. There are two major forms of the disease: sporadic (SAD) - whose causes are not completely understood - and familial (FAD) - with clear autosomal dominant inheritance. The two main hallmarks of AD are extracellular deposits of amyloid-beta (Ab) peptide and intracellular deposits of the hyperphosphorylated form of the tau protein (P-tau). An ever-growing body of research supports the infectious hypothesis of sporadic forms of AD. Indeed, it has been documented that some pathogens, such as herpesviruses and certain bacterial species, are commonly present in AD patients, prompting recent clinical research to focus on the characterization of Antimicrobial Peptides (AMPs) in this pathology. Literature also demonstrates that Ab can be considered itself as an AMP thus representing a type of innate immune defense peptide that protect the host against a variety of pathogens. Beyond Ab, other proteins with antimicrobial activity, such as lactoferrin, defensins, cystatins, thymosin β4, LL37, histatin 1 and statherin have been shown to be involved in AD. Here we have summarized and discussed these findings and explored the diagnostic and therapeutic potential of AMPs in AD.

The number of people owning vehicles has been steadily growing, resulting in increased numbers of vehicles on the roads, making roads more congested, and increasing the risk of accidents. In addition, heavy rain, snow, and fog have increased due to abnormal weather caused by global warming. These bad weather conditions can also affect the safety of vehicles and drivers. The need to disseminate safety messages on the social internet of vehicles due to these problems has been steadily increasing. In this paper, we propose an efficient safety message dissemination scheme that focuses on urban environments with high vehicle density and mobility to address these problems. The proposed scheme reduces packet loss by considering frequent cluster departures and subscriptions through an efficient cluster management technique. In a vehicle-to-vehicle environment, the dissemination of safety messages is divided into an intra-cluster and an inter-cluster emergency as well as general safety message dissemination technique. In a vehicle to infrastructure environment, the proposed scheme reduces the number of processing requests and duplicate messages made to roadside units (RSUs) through a request operation process for each vehicle and an RSU scheduling technique. We conducted several performance evaluations of message packet loss and the number of RSU processing requests to demonstrate the superiority of the proposed scheme.

A cross-flow ultrafiltration harvesting system of a pre-concentrated microalgae culture was tested in an innovative anaerobic-based WRRF. The microalgae culture was cultivated in a membrane photobioreactor fed with the effluent from an anaerobic membrane bioreactor treating sewage. These harvested microalgae biomass was then anaerobically co-digested with primary and secondary sludge from the water line. Depending on the needs of this anaerobic co-digestion, the filtration harvesting process was evaluated intermittently over a period of 212 days for different operating conditions, mainly the total amount of microalgae biomass harvested and the desired final total solids concentration (up to 15.9 g·L1 with an average of 9.7 g·L1). Concentration ratios of 15-27 were obtained with average transmembrane fluxes ranged from 5 to 28 L·m2·h1. Regarding membrane cleaning, both backflushing and chemical cleaning resulted in transmembrane flux recoveries that were, on average, 21% higher than those achieved with backflushing alone. The carbon footprint assessment shows promising results as the GHG emissions associated with the cross-flow ultrafiltration harvesting process could be less than the emissions savings associated with the energy recovered from the biogas production from the anaerobic valorisation of the harvested microalgae.

Background: This practice guideline was developed by the Chronic Kidney Disease (CKD) Task Force, which was composed of clinical and methodological experts. The Saudi Arabian Ministry of Health and its Health Holding Company commissioned this guideline project to support the realization of the Vision 2030's healthcare transformation pillar. Methods: The guideline synthesis was guided by the GRADE-ADOLOPMENT methodology. Results: The final adoloped guideline addressed 12 clinical questions on blood pressure management in patients with CKD through a set of recommendations and performance measures. The recommendations included antihypertensive agents in children, non-renin angiotensin system inhibition (Non-RASi) vs RASi in adults, intensive vs standard blood pressure targets, early vs late assessment for kidney replacement therapy (KRT), late vs early preparation strategy for KRT, CKD symptoms during assessment for KRT or conservative management, initiation of KRT in patients with deteriorating CKD, choice of KRT modality or conservative management in certain CKD patient groups, changing or discontinuing KRT modalities, review frequency for KRT or conservative management, and Information, education and support. Conclusions: These conditional recommendations were based on low to very low certainty of evidence that highlights the need for high-quality randomized trials comparing different antihypertensive agents in patients with CKD.

Effective therapeutics for Alzheimer's disease (AD) are in great demand worldwide. In our previous work, we responded to this need by synthesizing novel drug candidates consisting of 4-amino-2,3-polymethylenequinolines conjugated with butylated hydroxytoluene via fixed-length alkylimine or alkylamine linkers (spacers) and studying their bioactivities pertaining to AD treatment. Here, we report significant extensions of these studies, including the use of variable-length spacers and more detailed biological characterizations. Conjugates were potent inhibitors of acetylcholinesterase (AChE, minimum IC50 15.1±0.2 nM) and butyrylcholinesterase (BChE, minimum IC50 5.96±0.58 nM), with weak inhibition of off-target carboxylesterase. Conjugates with alkylamine spacers were more effective cholinesterase inhibitors than alkylimine analogs. Optimal inhibition for AChE was exhibited by cyclohexaquinoline and for BChE by cycloheptaquinoline. Increasing spacer length elevated potency against both cholinesterases. Structure-activity relationships agreed with docking results. Mixed-type reversible AChE inhibition, dual docking to catalytic and peripheral anionic sites, and propidium iodide displacement suggested the potential of hybrids to block AChE-induced β-amyloid (Aβ) aggregation. Hybrids also exhibited inhibition of Aβ self-aggregation in the thioflavin test; those with a hexaquinoline ring and C8 spacer were the most active. Conjugates demonstrated high antioxidant activity in ABTS and FRAP assays as well as inhibition of luminol chemiluminescence and lipid peroxidation in mouse brain homogenates. Quantum-chemical calculations explained antioxidant results. Computed ADMET profiles indicated favorable blood-brain barrier permeability suggesting CNS activity potential. Thus, the conjugates could be considered promising multifunctional agents for potential treatment of AD.

The assessment of welfare and disease progression in animal models is critical. Most tools rely on evaluating individual subjects, whereas social behaviors, also sensitive to acute illness, chronic diseases, or mental health, are scarcely monitored because of their complexity, are invasive, and time-consuming. We propose the evaluation of social nesting, a species-typical behavior naturally occurring in standard housing conditions, for such behavioral monitoring. We provide an example of its use to evaluate social deficits and the long-term effects of neonatal sensorial stimulation in male and female adult 3xTg-AD mice for Alzheimer's disease compared to sex- and age-matched NTg counterparts with normal aging. Social nesting was sensitive to genotype (worse in 3xTg-AD mice), sex (worse in males), profile, and treatment (distinct temporal patterns, time to observe the maximum score and incidence of the perfect nest). Since social nesting can be easily included in housing routines, this neuroethological approach can be useful for animal's welfare, monitoring the disease's progress, and evaluating potential risk factors and effects of preventive/therapeutical strategies. Finally, the non-invasive, painless, simple, short time and low-cost features of this home-cage monitoring are advantages that make social nesting feasible to be successfully implemented in most animal department settings.

Alzheimer’s Disease (AD) has no cure. Earlier, we showed that partial inhibition of mitochondrial complex I (MCI) with small molecule CP2 induces adaptive stress response activating multiple neuroprotective mechanisms. Chronic treatment reduced inflammation, improved synaptic and mitochondrial functions, and blocked neurodegeneration in symptomatic APP/PS1 mice, a translational model of AD. Here, using serial block-face scanning electron microscopy (SBFSEM) and three-dimensional (3D) EM reconstructions combined with Western blot analysis and next-generation RNA sequencing, we demonstrate that CP2 treatment also restores mitochondrial morphology and mitochondria-endoplasmic reticulum (ER) communication in the APP/PS1 mouse brain. Using 3D EM volume reconstructions, we show that mitochondria in AD dendrites exist primarily as mitochondria-on-a-string (MOAS). Compared to other morphological phenotypes, MOAS are extensively enveloped in the ER membranes forming multiple mitochondria-ER contact sites (MERCS) known to contribute to abnormal lipid and calcium homeostasis. CP2 treatment specifically reduced MOAS formation, consistent with improved energy homeostasis in the brain, with concomitant reduction in MERCS, ER stress, and improved lipid homeostasis. These data provide novel information on the role MOAS play in AD and additional support for further development of partial MCI inhibitors as disease modifying strategy for AD.

A large body of evidence, replicated in many mouse models of Alzheimer Disease (AD), demonstrated the therapeutic efficacy of oral rapamycin. Administration of m-TOR inhibitors (mTOR-Is), early after the clinical onset, greatly diminished cognitive impairment, amyloid angiopathy, intracellular beta Amyloid and neurofibrillary tangles load. The daily intake of rapamycin has always been 2.24g/Kg/24h. In humans the maximal tolerated oral dose is a few milligrams/day, and at this dosage patients are severely immunosuppressed. Thanks to rapalogs’ scarce CNS-related side effects, we administered intracerebroventricularly (ICV) high doses of the mTOR-I everolimus in a mouse model of AD (3xTg-AD) without significant systemic effects. The instability of the liquid formulation at body temperature (BT) made the treatment very short. Nevertheless, the efficacy of the treatment was high and much longer lasting than expected. In order to set up a thermostable, translational liquid formulation of mTOR-Is, we loaded everolimus in distearoylphosphatidylethanolamine-polyethylene glycol 2000 (DSPE-PEG2000) micelles by the thin layer method. The formulation we obtained maintained over 95% of activity after 14 days at BT. We can envision short, potentially periodic ICV treatments in AD patients which replicate results obtained on animal models. The treatment could benefit also Tuberous Sclerosis and Multiple Sclerosis patients.

Premature ovarian insufficiency (POI) is a highly prevalent disorder, characterized by the development of menopause before age of 40. Most cases are idiopathic; however, in some women the cause of this condition (e.g. anticancer treatment, genetic disorders, and enzymatic defects) may be identified. Although hormone replacement therapy, the principal therapeutic approach for POI, helps to alleviate the related symptoms, this does not effectively solve the issue of fertility. Assisted reproductive techniques also lack efficacy in these women. Thus, the effective approach to manage the patients with POI is highly warranted. Several mechanisms, associated with POI, have been identified, including lack of FSH receptor functioning, alterations in the apoptosis control, mutations in Sal-like 4 genes, thymulin or basonuclin-1 deficiency etc. The above-mentioned may be good targets for gene therapy in order to correct defects, leading to POI. The goal of this review is to summarize the current experience on the POI studies, that employed gene therapy, and to discuss the possible future directions in this field.

The Internet of Things (IoT) is a technological paradigm that has gained significant momentum that last decade and, among others, enables the development of intelligent and interoperable device networks. In this respect, it has triggered the creation and evolution of VANETs (Vehicular Ad Hoc Networks), which are initially implemented in order to guarantee the safety of the drivers and the avoidance of traffic accidents. The drawback is that this fast evolution flags serious concerns as far as the privacy of users is concerned, while the population of attackers or entities that try to eavesdrop and intercept information has significantly increased. This imposes a serious risk for drivers moving across a Smart City. The research presented in this paper aims to evaluate privacy protection mechanisms in VANET environments, based on their efficiency and security level ensured, considering the fact that VANETs provide limited resources to users/drivers. Moreover, the usage of the elliptic curve cryptography in reduced resources environments is discussed. Finally, this paper compares the performance of three cryptographic algorithms, i.e., Elliptic Curve Cryptography (ECC), Hyperelliptic Curve Cryptography genus 2 (HECC-2) and HECC genus 3 (HECC-3), employed for an efficient authentication and safe message transmission mechanism in VANETs, targeting to extract conclusions related to the implementation of each cryptographic scheme in this specific application area.

Alzheimer's disease (AD) is the most prevalent form of dementia. With the global aging population, the incidence of AD and related dementias is projected to rise dramatically, posing significant public health challenges. Traditionally, the diagnosis of AD has relied on the detection of amyloid-beta (Aβ) plaques and neurofibrillary tangles of hyperphosphorylated tau in the brain, assessed through invasive cerebrospinal fluid (CSF) analysis and costly positron emission tomography scans. However, these methods are not feasible for widespread screening or use in low-resource settings. Recent advances in blood-based biomarkers offer a promising alternative for the early detection and monitoring of AD. These biomarkers provide a minimally invasive, cost-effective means of tracking the pathological progression of AD before the onset of clinical symptoms, potentially enabling earlier and more accurate diagnosis. Blood-based biomarkers, including those related to Aβ, phosphorylated tau, and neurofilament light polypeptide, have demonstrated significant potential in reflecting the underlying neuropathology of AD and correlating with traditional CSF and imaging biomarkers. This review synthesizes the latest research on blood-based biomarkers in AD, highlighting their role in the disease's etiopathogenesis, diagnostic accuracy, and prognostic value. We discuss the emerging evidence on proteinopathies, neuroinflammation, vascular pathology, and bioenergetic profiles, emphasizing the clinical applicability of these biomarkers. Furthermore, we explore the integration of blood-based biomarkers with advanced neuroimaging techniques and their potential to revolutionize the diagnostic landscape of AD, particularly in resource-limited settings. We have integrated protein-protein interaction (PPI) and miRNA network analyses to enhance the analysis. By incorporating these, we can explore the interactions and relationships between different proteomic, genomic, and epigenomic biomarkers, potentially unveiling new insights into the underlying biological mechanisms of AD. The continued development and validation of these biomarkers could lead to more accessible and equitable AD diagnostics, ultimately improving patient outcomes.

Vehicle-to-Vehicle (V2V) communication plays a pivotal role in modern intelligent transportation systems, enabling seamless information exchange among vehicles to enhance road safety, traffic efficiency, and overall driving experience. However, the secure transmission of sensitive data between vehicles remains a critical concern due to potential security threats and vulnerabilities. This research paper focuses on investigating the security protocols employed in Vehicle-to-Vehicle communication systems. A comprehensive review and analysis of relevant literature and research papers is conducted to gather information on existing V2V communication security protocols and techniques. The analysis encompasses key areas, including authentication mechanisms, encryption algorithms, key management protocols, and intrusion detection systems specifically applicable to V2V communication networks. Within the context of real-world V2V environments, this study delves into the challenges and limitations associated with implementing these protocols. Moreover, to foster a deeper understanding, the paper investigates present communication protocols in the field of Internet of Things (IoT) that are tailored for V2V. Various parameters, such as band-width consumption, energy consumption, latency, and message size, are considered during the evaluation of these protocols to gauge their effectiveness. The research outcomes aim to provide a comprehensive understanding of the strengths and weaknesses of the current V2V communication security protocols. Furthermore, based on the findings, this paper will propose improvements and recommendations to enhance the security measures of the V2V communication protocol. Ultimately, this research will contribute to the development of more secure and reliable V2V communication systems, propelling the advancement of intelligent transportation technology.

Human endogenous retroviruses (HERV) are remnants of ancient retroviral infections that, over millions of years, became integrated into the human genome. While normally inactive, environmental stimuli such as infections have contributed to the transcriptional reactivation of HERV promoting pathological conditions including the development of autoimmunity, neurodegenerative disease and cancer. What infections then trigger HERV activation? Mycobacterium avium subspecies paratuberculosis (MAP) is a pluripotent driver of human disease. Aside from granulomatous diseases Crohn’s, sarcoidosis and Blau syndrome, MAP is associated with autoimmune disease: type one diabetes (T1D), multiple sclerosis (MS), rheumatoid arthritis and autoimmune thyroiditis. MAP is also associated with Parkinson’s disease. Autoimmune diabetes, multiple sclerosis and rheumatoid arthritis are the diseases with the strongest MAP/HERV association. There are several other diseases associated with HERV activation including diseases whose epidemiology and/or pathology would prompt speculation for a causal role of MAP. These include non-solar uveal melanoma, colon cancer, glioblastoma and amyotrophic lateral sclerosis (ALS). This article further points to MAP infection as a contributor to autoimmunity, neurodegenerative disease and cancer via unsilencing of HERV. We examine the link between the ever-increasing number of MAP- associated diseases, the MAP/HERV intersection with these diverse medical conditions and propose treatment opportunities based upon this association.